(RTTNews) - Rhythm Pharmaceuticals, Inc. (RYTM) revealed Loss for its third quarter that increased from last year and missed the Street estimates.
The company's bottom line totaled -$54.28 million, or -$0.82 per share. This compares with -$44.97 million, or -$0.73 per share, last year.
Analysts on average had expected the company to earn -$0.73 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 54.3% to $51.30 million from $33.25 million last year.
Rhythm Pharmaceuticals, Inc. earnings at a glance (GAAP) :
-Earnings: -$54.28 Mln. vs. -$44.97 Mln. last year. -EPS: -$0.82 vs. -$0.73 last year. -Revenue: $51.30 Mln vs. $33.25 Mln last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
